Bioabsorbable Everolimus-Eluting Stent: 6-Month Angiographic and IVUS Results
Patrick Serruys
Spencer King
PATRICK SERRUYS, Erasmus University, Rotterdam
COMMENT: SPENCER KING, Piedmont Hospital, Atlanta
REFERENCE: Abstract 2402-3, American College of Cardiology New Orleans
Six-months follow-up of patients receiving a new bioabsorbable drug-eluting stent are favourable, according to Patrick Serruys…
Six-months follow-up of patients receiving a new bioabsorbable drug-eluting stent are favourable, according to Patrick Serruys…